Researchers develop innovative non-addictive painkiller for chronic pain
HQ Team November 13, 2024: A team of international researchers has developed a non-addictive painkiller that remains inactive until it reaches sites of.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team November 13, 2024: A team of international researchers has developed a non-addictive painkiller that remains inactive until it reaches sites of.
A clinical-stage US gene-editing company, Precision BioSciences, got approval from the Eastern European country of Moldova to start an in vivo human trial.
Amplifica Holdings Group Inc.’s first-in-human trial of an injectable medicine for treating hair loss has shown a more than 15% increase in non-vellus.
HQ team August 23, 2024: .An mRNA-based lung cancer vaccine is being tested for the first time on patients in the UK. Known.
Bharti Jayshankar February 5, 2024: Scientists have developed a form of oral insulin, offering an alternative to traditional syringes or insulin pumps. The.
HQ Team January 11, 2023: The first human trials for a vaccine against Nipah virus have been started by the University of Oxford,.
HQ Team September 20, 2023: Elon Musk’s Neuralink Corp., got a nod from an independent institutional review board to start recruiting for a.
HQ Team May 17, 2023: The first trial on humans of an experimental oral drug for removing radioactive contaminants from inside the body.